Rosuvastatin renal failure

Jul 20, 2022 · Among the findings: Users of rosuvastatin had an 8% higher risk for hematuria, a 17% higher risk for proteinuria, and a 15% higher risk for kidney failure with replacement therapy compared with Therefore, it is clear that rosuvastatin, and other statins, are very safe and useful agents and do not appear to present significant risks to hepatic or renal safety. A new study is sounding the alarm on the potential increase in risk of kidney damage observed with use of Cases of myopathy [muscle pain, tenderness, or weakness associated with elevated creatine kinase (CK)] and rhabdomyolysis and rhabdomyolysis with acute renal failure secondary to myoglobinuria reported with HMG-CoA reductase inhibitors; may occur at any dose level, but are increased at the highest dose (40 mg); caution in patients with Feb 3, 2015 · Renal adverse events were reported by five (4·5%) patients in the atorvastatin 80 mg group, nine (7·8%) patients in the rosuvastatin 10 mg group, and 12 (9·8%) patients in the rosuvastatin 40 mg group

2024-03-28
    Glipizide xr dosing
  1. 3,14 Adverse events were reported in
  2. kidney disease
  3. Lancet
  4. Descriptions